PHOENIX, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. ("Insys" or "the Company") (NASDAQ:INSY) today issued the following statement regarding the Department of Justice / U.S. Attorney's Office / District of Massachusetts press release:

The charges against individuals discussed in the DOJ press release relate to previously disclosed investigations. Insys continues to cooperate with all relevant authorities in its ongoing investigations and is committed to complying with laws and regulations that govern our products and business practices.  Insys will not provide additional information or comments at this time on this matter.

About Insys Therapeutics, Inc.

Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of life of patients.
Investor Contact:Lisa M. WilsonEmail:

Primary Logo